FTC Looks To Ax Cephalon Patent Experts In Antitrust Case
The Federal Trade Commission urged a Pennsylvania federal court Friday to block Cephalon Inc. from having 10 experts testify about its patent for narcolepsy drug Provigil in the watchdog's pay-for-delay case...To view the full article, register now.
Already a subscriber? Click here to view full article